Association for Prescription Psychedelics
Industry association representing pharmaceutical companies
Based in NY
AI Overview
With $60K in lobbying spend across 3 quarterly filings, Association for Prescription Psychedelics is an active lobbying client. Their lobbying covers 1 issue area.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Association for Prescription Psychedelics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to psychedelic therapies and the FDA
FDA approval and regulation of prescription psychedelic therapies
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.